Filter
1568
Text search:
liver
Featured
212
423
Language
Document type
949
250
160
76
44
43
27
5
4
4
2
2
1
1
Countries / Regions
132
63
44
44
33
31
27
27
24
23
23
22
21
21
19
18
17
17
15
14
13
12
11
11
11
11
9
8
8
7
7
7
6
6
6
6
5
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
585
283
87
82
47
24
16
Toolboxes
129
120
95
89
78
52
46
45
43
40
37
26
19
13
11
11
11
9
5
5
3
3
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
A Summary
Accessed: 23.11.2019
International Journal of Infectious Diseases 80 (2019) 10–15
journal homepage: www.elsevier.com/locate/ijid
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Accessed: 27.11.2019
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
“Continuum of HIV services refers to a comprehensive package of HIV prevention, diagnostic, treatment, care and support services provided for people at risk of HIV infection or living with HIV and their families”
August, 2018
A healthcare worker manual. 2nd edition
The development of this National Manual for the Management of HIV-related Opportunistic Infections and Conditions for use by health care workers at the frontline of our fight against HIV/AIDS is intended to improve their understanding of the causes, preventio
...
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
Октябрь 2017
Русский
Рекомендации EACS 9.0
Technical Update
HIV Treatment
July 2017
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Accessed Febr. 6, 2020
Accessed Febr.6, 2020
Accessed Febr. 6, 2020